FOLH1 and prostate carcinoma: 225Ac-PSMA-R2 is an alpha-emitting radioligand composed of Actinium-225 linked to a PSMA-targeting ligand, enabling high-energy radiation delivery to PSMA-positive prostate cancer cells.